Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-31

Clinical Trial Update: A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial evaluating NS/GEMOX chemotherapy in patients with untreated pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NS/GEMOX chemotherapy

Snippet

Sponsor: Yanqiao Zhang | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN